It originated as part of Lilly's program to extend the dual-agonist concept proven by tirzepatide into a triple-agonist class, and it is the first such molecule to advance into Phase 3 in any indication [1][3][4]
SVIA Medspa in Los Gatos and San Mateo offers Ozempic and Zepbound, FDA-approved options administered through a simple weekly injection
The authors explain that the reported wound-healing activity of TB-500 in literature may be due to its metabolite Ac-LKKTE rather than the parent form.30 Additionally, there have been some positive preclinical research outcomes for the use of TB4 for hair growth,31 neuroprotection,32 tympanic membrane perforations,33 and decreasing mortality in sepsis, but more clinical research is needed before these potential benefits can be considered applicable to humans.5 Are TB4 and TB-500 safe
Integrating Peptide Therapy into Existing Treatment Protocols Peptide therapies can be easily incorporated into current treatment regimens for chronic conditions
With 476,857 individuals across 18 different countries (propensity score matched 1:1 with pregnant controls), this is the largest study to date in this historically underserved population